Christian Weyer

Antiobesity effects of the β-cell hormone amylin in combination with phentermine or sibutramine in diet-induced obese rats

C. Weyer, D. Parkes, C. Mack, 2008, International Journal of Obesity.

Amylin replacement with pramlintide as an adjunct to insulin therapy in type 1 and type 2 diabetes mellitus: a physiological approach toward improved metabolic control.

C. Weyer, A. Young, D. Maggs, 2001, Current pharmaceutical design.

Addition of pramlintide to insulin therapy lowers HbA1c in conjunction with weight loss in patients with type 2 diabetes approaching glycaemic targets

C. Weyer, M. Fineman, D. Maggs, 2003, Diabetes, obesity & metabolism.